دورية أكاديمية
أعرض في EDS

Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID-19 pandemic: A 24-month cohort study.

التفاصيل البيبلوغرافية
العنوان: Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID-19 pandemic: A 24-month cohort study.
المؤلفون: de Oliveira TJ; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Altoé ID; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Arpini LDSB; Nossa Senhora da Glória Children's State Hospital, Vitória, Espírito Santo, Brazil., Liberato FMG; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Melotti RCNC; Nossa Senhora da Glória Children's State Hospital, Vitória, Espírito Santo, Brazil., Wittmer VL; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Duarte H; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Barbalho-Moulim MC; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil., Paro FM; Department of Integrated Education on Health, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
المصدر: Pediatric pulmonology [Pediatr Pulmonol] 2024 Jul; Vol. 59 (7), pp. 1962-1969. Date of Electronic Publication: 2024 May 07.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8510590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-0496 (Electronic) Linking ISSN: 10990496 NLM ISO Abbreviation: Pediatr Pulmonol Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005-> : Hoboken, NJ : Wiley-Liss
Original Publication: [Philadelphia, PA] : W.B. Saunders, [c1985-
مواضيع طبية MeSH: Cystic Fibrosis*/epidemiology , Cystic Fibrosis*/complications , Cystic Fibrosis*/physiopathology , COVID-19*/epidemiology , Body Mass Index*, Humans ; Male ; Female ; Child ; Adolescent ; Longitudinal Studies ; SARS-CoV-2 ; Child, Preschool ; Anthropometry ; Body Weight ; Body Height ; Exocrine Pancreatic Insufficiency/epidemiology ; Exocrine Pancreatic Insufficiency/etiology ; Cohort Studies ; Infant
مستخلص: Objectives: To analyze the evolution of clinical and anthropometric characteristics of children and adolescents with cystic fibrosis (CF) over 24 months, including the period of the COVID-19 pandemic.
Methods: A longitudinal study with data collection from May 2018 to November 2020 in physical and electronic records from a pediatric reference center, including individuals with CF aged up to 18 years.
Results: The sample encompassed 72 individuals. Weight (p < 0.01), height (p < 0.01), and body mass index (BMI) (p = 0.043) were higher in 2020 than in 2018. There were no significant changes in BMI-Z (p = 0.977) and in percentiles of weight (p = 0.540), height (p = 0.458), and BMI percentile (p = 0.454) between both periods. Pancreatic insufficiency was observed in 91.7% of patients in 2020, and there were twice as many confirmed cases of diabetes compared to 2018. There was a 9.7% increase in individuals colonized by the oxacillin-sensitive Staphylococcus aureus (OSSA) (p = 0.039) and an 11.1% reduction in non-colonized individuals (p = 0.008).
Conclusion: Although there was an increase in weight, height, and BMI from 2018 to 2020, there were no significant changes in BMI-Z and in percentiles of weight, height, and BMI percentile, suggesting that the anthropometric aspects of nutritional status did not change in this period of 2 years. Moreover, there was an increase in the prevalence of individuals colonized by OSSA and a reduction in the prevalence of individuals non-colonized with any bacteria.
(© 2024 Wiley Periodicals LLC.)
References: Grasemann H, Ratjen F. Cystic fibrosis. N Engl J Med. 2023;389(18):1693‐1707. doi:10.1056/NEJMra2216474.
Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective. Lancet Resp Med. 2020;8(1):65‐124. doi:10.1016/S2213-2600(19)30337-6.
Kerem E. Cystic fibrosis: priorities and progress for future therapies. Paediatr Respir Rev. 2017;24:14‐16.
Hauschild DB, Rosa AF, Ventura JC, et al. Association of nutritional status with lung function and morbidity in children and adolescents with cystic fibrosis: a 36‐month cohort study. Rev Paul Pediatr. 2018;36:31‐38.
Calella P, Valerio G, Brodlie M, Donini LM, Siervo M. Cystic fibrosis, body composition, and health outcomes: a systematic review. Nutrition. 2018;55‐56:131‐139.
Haack A, Carvalho Garbi Novaes MR. Multidisciplinary care in cystic fibrosis; a clinical‐nutrition review. Nutr Hosp. 2012;27:362‐371.
Turck D, Braegger CP, Colombo C, et al. ESPEN‐ESPGHAN‐ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557‐577.
Graziano S, Boldrini F, Righelli D, et al. Psychological interventions during COVID pandemic: telehealth for individuals with cystic fibrosis and caregivers. Pediatr Pulmonol. 2021;56(7):1976‐1984. doi:10.1002/ppul.25413.
Collaço N, Legg J, Day M, et al. COVID‐19: impact, experiences, and support needs of children and young adults with cystic fibrosis and parents. Pediatr Pulmonol. 2021;56(9):2845‐2853. doi:10.1002/ppul.25537.
Athanazio RA, Silva Filho LVRF, Vergara AA, et al. Brazilian guidelines for the diagnosis and treatment of cystic fibrosis. Jornal Brasileiro de Pneumologia. 2017;43:219‐245.
De Onis M. Development of a WHO growth reference for school‐aged children and adolescents. Bull World Health Organ. 2007;85:660‐667.
Neri LCL, Simon MISS, Ambrósio VLS, et al. Brazilian guidelines for nutrition in cystic fibrosis. Einstein. 2022;20:eRW5686. doi:10.31744/einstein_journal/2022RW5686.
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Orientações para a coleta e análise de dados antropométricos em serviços de saúde: Norma Técnica do Sistema de Vigilância Alimentar e Nutricional ‐ SISVAN/Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. Brasília: Ministério da Saúde, 2011; 76. https://bvsms.saude.gov.br/bvs/publicacoes/orientacoes&#95;coleta&#95;analise&#95;dados&#95;antropometricos.pdf.
Aidoo E, Alexander S, Alshaf K, et al. Clinical guidelines: care of children with cystic fibrosis. Royal Brompton & Harefield Hospitals [Internet]. 9th ed. Ian Balfour‐Lynn154; 2023. https://www.rbht.nhs.uk/childrencf.
Alves C, Della‐Manna T, Albuquerque CTM. Cystic fibrosis‐related diabetes: an update on pathophysiology, diagnosis, and treatment. J Pediatr Endocrinol Metabolism. 2020;33(7):835‐843.
Granados A, Chan CL, Ode KL, Moheet A, Moran A, Holl R. Cystic fibrosis‐related diabetes: pathophysiology, screening and diagnosis. J Cys Fibr. 2019;18:S3‐S9.
Rodrigues DCS, Lima DF, Cohen RWF, Marques EA, Leão RS. Molecular characterisation of methicillin‐resistant Staphylococcus aureus from chronically colonised cystic fibrosis paediatric patients in Brazil. Epidemiol Infect. 2020;148(e149):e149. doi:10.1017/S0950268820001156.
Hatziagorou E, Orenti A, Drevinek P, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European Cystic Fibrosis Society Patient Registry. J Cys Fibr. 2020;19:376‐383.
Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cy Fibr. 2015;14:293‐304.
Cystic Fibrosis Foundation Patient Registry 2021. Annual data report, Bethesda, Maryland; ©2022 Cystic Fibrosis Foundation. https://www.cff.org/sites/default/files/2021-11/Patient-Registry-Annual-Data-Report.pdf.
Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15:194‐222.
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91‐100.
Salsgiver EL, Fink AK, Knapp EA, et al. Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis. Chest. 2016;149:390‐400.
Walkowiak J, Lisowska A, Blaszczyński M. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype. Eur J Gastroenterol Hepatol. 2008;20(3):157‐160.
McKay IR, Ooi CY. The exocrine pancreas in cystic fibrosis in the era of CFTR modulation: a mini‐review. Front Pediatr. 2022;10:914790.
Konstan MW, Butler SM, Wohl MEB, et al. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr. 2003;142:624‐630.
Silva LA, Lima ACP, Wittmer VL, Liberato FMG, Arpirini LSB, Paro FM. Quality of life of children and adolescents with cystic fibrosis: the importance of body image and the impact of nutritional status, age and race/skin color on patients’ and caregivers’ perceptions. Demetra. 2018;13(3):675‐693. doi:10.12957/demetra.2018.32295.
Dediu M, Ciuca IM, Marc MS, Boeriu E, Pop LL. Factors influencing lung function in patients with cystic fibrosis in Western Romania. J Multidiscip Healthc. 2021;14:1423‐1429. doi:10.2147/JMDH.S313209.
Borowitz D, Baker RD, Stallings V, Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35:246‐259.
Neri LCL, Bergamaschi DP, Silva Filho LVRF. Evaluation of nutritional status in patients with cystic fibrosis according to age group. Rev Paul Pediatr. 2019;37:58‐64.
Módulo LP, Uliana LB, Liberato FMG, et al. Adherence to chest physiotherapy, airway clearance techniques and physical exercise by children and adolescents with cystic fibrosis. J Human Growth Develop. 2024;34(1):78‐88. doi:10.36311/jhgd.v34.15779.
Hatziagorou E, Toulia I, Avramidou V, Kampouras A, Tsara V, Tsanakas J. Change in CF care during COVID‐19 pandemic: single‐center experience in a middle‐income setting. Pediatr Pulmonol. 2021;56(9):3065‐3067. doi:10.1002/ppul.25560.
Junior FGP, Paiano R, Costa SA. Social isolation: physical and mental consequences of physical inactivity in children and adolescents. Rev Bras Ativ Fis Saúde. 2020;25:e0115.
Zachary Z, Brianna F, Brianna L, et al. Self‐quarantine and weight gain related risk factors during the COVID‐19 pandemic. Obesity Res Clin Practice. 2020;14:210‐216.
Kayani K, Mohammed R, Mohiaddin H. Cystic fibrosis‐related diabetes. Front Endocrinol. 2018;9. doi:10.3389/fendo.2018.00020.
Hart NJ, Aramandla R, Poffenberger G, et al. Cystic fibrosis‐related diabetes is caused by islet loss and inflammation. JCI Insight. 2018;3:e98240.
Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis‐related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32:1626‐1631.
Doan LV, Madison LD. Cystic fibrosis‐related diabetes. StatPearls [Internet]. StatPearls Publishing; 2024.
Colombo C, Burgel PR, Gartner S, et al. Impact of COVID‐19 on people with cystic fibrosis. Lancet Respir Med. 2020;8:e35‐e36. doi:10.1016/S2213-2600(20)30177-6.
فهرسة مساهمة: Keywords: COVID‐19; anthropometry; children; cystic fibrosis; pandemics
تواريخ الأحداث: Date Created: 20240507 Date Completed: 20240720 Latest Revision: 20240720
رمز التحديث: 20240721
DOI: 10.1002/ppul.27027
PMID: 38712790
قاعدة البيانات: MEDLINE
الوصف
تدمد:1099-0496
DOI:10.1002/ppul.27027